2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Ciliary Body Melanoma
Ciliary body melanoma is a rare form of eye cancer that arises from the pigment-producing cells in the ciliary body, a part of the eye responsible for producing aqueous humor. Despite its rarity, it poses significant challenges due to its potential for aggressive growth and metastasis. Current research in cancer biology is focused on elucidating the molecular mechanisms underlying its development and progression, with an aim to identify novel therapeutic targets. Treatment typically involves a combination of surgery, radiation therapy, and sometimes chemotherapy, but the prognosis remains guarded, emphasizing the need for more effective and targeted therapies. Advances in genetic profiling and immunotherapy offer promising avenues for personalized treatment strategies, ultimately improving outcomes for patients with ciliary body melanoma.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China